Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017

Fig. 2

Resistance level and TDR prevalence trend. a. TDR prevalence trend from 2009 ~ 2017. Rates (mean, Std. Error, 95% CI) of TDR in Chinese: 2009–2011 (3/90, 3.30%, Std. Error: 1.9, 0.00% ~ 7.60%), 2012–2013 (3/64, 4.70%, Std. Error: 2.66, 0.00% ~ 10.9%), 2014–2015 (3/47, 6.4%, Std. Error: 3.6, 0.00% ~ 14.6%), 2016–2017 (7/118, 5.90%, Std. Error: 2.20, 1.80% ~ 10.7%); Burmese: 2009–2011 (1/25, 4.00%, Std. Error: 4.00, 0.00% ~ 13.6%), 2012–2013 (2/49, 4.10%, Std. Error: 2.8, 0.00% ~ 10.4%), 2014–2015 (2/66, 3.00%, Std. Error: 2.1, 0.00% ~ 7.70%), 2016–2017 (15/114, 13.20%, Std. Error: 3.10, 7.40% ~ 19.7%). b. Resistance levels of TDRMs. The degrees of resistance of the observed TDRMs to 20 ART drugs from the Stanford HIVDB program are distinguished by colors. The effects of other non-SDRMs in the sequence are excluded

Back to article page
\